Padmanabh P. Bhatt - Jan 6, 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Sr. VP of IP, CSO
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Jan 6, 2023
Transactions value $
-$5,354
Form type
4
Date filed
1/9/2023, 04:00 PM
Previous filing
Dec 2, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $1.59K +174 +10.58% $9.13 1.82K Jan 6, 2023 Direct F1
transaction SUPN Common Stock Sale -$6.94K -174 -9.57% $39.90 1.64K Jan 6, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Employee Stock Option (Right to Buy) Options Exercise $0 -174 -1.74% $0.00 9.83K Jan 6, 2023 Common Stock 174 $9.13 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted September 8, 2022.
F2 The option vested in four equal annual installments beginning on March 3, 2016.